Video
Author(s):
OncLive interviewed experts at the State of the Science Summits™ in February 2020 on common misconceptions in their respective fields.
OncLive interviewed experts at the State of the Science Summits™ in February 2020 on common misconceptions in their respective fields.
Casdatifan Demonstrates Durable Activity in Metastatic Clear Cell Renal Cell Carcinoma
IDE397 Shows Early Antitumor Activity, Safety in MTAP-Deletion Urothelial Cancer and NSCLC
RVU120 Shows Early Promise in R/R Metastatic or Advanced Solid Tumors
RMC-9805 Triggers Tumor Regressions in KRAS G12D–Mutant Pancreatic Cancer
2 Commerce Drive
Cranbury, NJ 08512